Related Experiment Video
Updated: Aug 15, 2025

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
Published on: June 25, 2018
Screening of Metabolism-Disrupting Chemicals on Pancreatic α-Cells Using In Vitro Methods
Reinaldo Sousa Dos Santos1,2, Ignacio Babiloni-Chust1,2, Laura Marroqui1,2
1Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández de Elche, 03202 Elche, Alicante, Spain.
Abstract:
Metabolism-disrupting chemicals (MDCs) are endocrine disruptors with obesogenic and/or diabetogenic action. There is mounting evidence linking exposure to MDCs to increased susceptibility to diabetes. Despite the important role of glucagon in glucose homeostasis, there is little information on the effects of MDCs on α-cells. Furthermore, there are no methods to identify and test MDCs with the potential to alter α-cell viability and function. Here, we used the mouse α-cell line αTC1-9 to evaluate the effects of MDCs on cell viability and glucagon secretion. We tested six chemicals at concentrations within human exposure (from 0.1 pM to 1 µM): bisphenol-A (BPA), tributyltin (TBT), perfluorooctanoic acid (PFOA), triphenylphosphate (TPP), triclosan (TCS), and dichlorodiphenyldichloroethylene (DDE). Using two different approaches, MTT assay and DNA-binding dyes, we observed that BPA and TBT decreased α-cell viability via a mechanism that depends on the activation of estrogen receptors and PPARγ, respectively. These two chemicals induced ROS production, but barely altered the expression of endoplasmic reticulum (ER) stress markers. Although PFOA, TPP, TCS, and DDE did not alter cell viability nor induced ROS generation or ER stress, all four compounds negatively affected glucagon secretion. Our findings suggest that αTC1-9 cells seem to be an appropriate model to test chemicals with metabolism-disrupting activity and that the improvement of the test methods proposed herein could be incorporated into protocols for the screening of diabetogenic MDCs.
Insights
Metabolism-disrupting chemicals (MDCs) can harm alpha-cells, impacting glucagon secretion and potentially diabetes risk. New methods using mouse alpha-cells can identify MDCs that affect cell viability and function.
Area of Science:
- Endocrinology
- Toxicology
- Cell Biology
Background:
- Metabolism-disrupting chemicals (MDCs) are endocrine disruptors linked to obesity and diabetes.
- Limited data exists on MDC effects on pancreatic alpha-cells, crucial for glucose homeostasis.
- Novel methods are needed to identify MDCs affecting alpha-cell function and viability.
Purpose of the Study:
- To evaluate the impact of six common MDCs on mouse alpha-cell viability and glucagon secretion.
- To establish and validate a testing model for identifying diabetogenic MDCs.
- To investigate the mechanisms underlying MDC-induced alpha-cell dysfunction.
Main Methods:
- Utilized the mouse alpha-cell line αTC1-9 for in vitro testing.
- Assessed cell viability using MTT assay and DNA-binding dyes.
- Measured glucagon secretion and analyzed reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress markers.
Main Results:
- Bisphenol-A (BPA) and tributyltin (TBT) reduced alpha-cell viability through estrogen receptor and PPARγ activation, respectively, inducing ROS.
- Perfluorooctanoic acid (PFOA), triphenylphosphate (TPP), triclosan (TCS), and dichlorodiphenyldichloroethylene (DDE) did not affect cell viability but impaired glucagon secretion.
- ER stress markers were minimally altered by the tested MDCs.
Conclusions:
- The αTC1-9 cell line is a suitable model for assessing MDC metabolism-disrupting activity.
- Proposed testing methods can be integrated into screening protocols for diabetogenic MDCs.
- MDCs differentially impact alpha-cell viability and function, highlighting the need for targeted risk assessment.

